Trial · NCT01576042
Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator
NCT01576042, Not applicable, Terminated, Duke University; results first posted 2014-09-25
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator. Trials, record NCT01576042. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01576042
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator
- NCT number
- NCT01576042
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 27 participants, actual
- Lead sponsor
- Duke University
- Conditions
- Ventricular Tachycardia
- Interventions
- amiodarone, sotalol, Biosense Webster's NAVI-STAR Thermo-Cool
- First posted
- 2012-04-12
- Last updated
- 2014-10-16
- Results first posted
- 2014-09-25
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants Completed Month 3 Follow-Up | 3 months | Records participants who completed Month 3 Follow-Up Visit |
| Secondary | Number of Participants Completed Month 6 Follow-Up | 6 Months | Records participants who completed Month 6 Follow-Up Visit |
| Secondary | Number of Participants Had at Least One of the Efficacy Outcome Measurement | 6 Months | Records participants who had at least one of the efficacy outcome measurement (including death, hospitalization due to VT) |
| Secondary | Cardiovascular Hospitalizations | Baseline, 6 months | Records participants hospitalized for VT during the study |
| Secondary | Number of Participants Remained on Randomized Treatment Assignment | 6 month | Records participants who only received study treatment as randomized during the entire study |
| Secondary | Number of Participants Switched to Other Arm | 6 months | Records participants who received study treatment as randomized and later switched to other treatment arm during the study |
| Secondary | Time to First Recurrent ICD Therapy for VT | Baseline, 6 months | Days from the date of the first study treatment to the date of first ICD recurrent therapy for VT. |
| Secondary | Number of Participants Received Treatment Assigned | 6 months | Records participants who received study randomized treatment during the study |
Source ClinicalTrials.gov
Outcomes8
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants Completed Month 3 Follow-Up | 3 months | participants | NUMBER | |
| SECONDARY | Number of Participants Completed Month 6 Follow-Up | 6 Months | participants | NUMBER | |
| SECONDARY | Number of Participants Had at Least One of the Efficacy Outcome Measurement | 6 Months | participants | NUMBER | |
| SECONDARY | Cardiovascular Hospitalizations | Baseline, 6 months | participants | NUMBER | |
| SECONDARY | Number of Participants Remained on Randomized Treatment Assignment | 6 month | participants | NUMBER | |
| SECONDARY | Number of Participants Switched to Other Arm | 6 months | participants | NUMBER | |
| SECONDARY | Time to First Recurrent ICD Therapy for VT | Baseline, 6 months | Days | MEAN | |
| SECONDARY | Number of Participants Received Treatment Assigned | 6 months | participants | NUMBER |
Source ClinicalTrials.gov
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Completed Month 3 Follow-Up | Catheter Ablation | 11 | participants | ||
| Number of Participants Completed Month 3 Follow-Up | Antiarrhythmic Medication | 12 | participants | ||
| Number of Participants Completed Month 6 Follow-Up | Catheter Ablation | 7 | participants | ||
| Number of Participants Completed Month 6 Follow-Up | Antiarrhythmic Medication | 10 | participants | ||
| Number of Participants Had at Least One of the Efficacy Outcome Measurement | Catheter Ablation | 11 | participants | ||
| Number of Participants Had at Least One of the Efficacy Outcome Measurement | Antiarrhythmic Medication | 14 | participants | ||
| Cardiovascular Hospitalizations | Catheter Ablation | 5 | participants | ||
| Cardiovascular Hospitalizations | Antiarrhythmic Medication | 7 | participants | ||
| Number of Participants Remained on Randomized Treatment Assignment | Catheter Ablation | 6 | participants | ||
| Number of Participants Remained on Randomized Treatment Assignment | Antiarrhythmic Medication | 13 | participants |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 results by groupParticipant flow8
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Catheter Ablation | 13 | |
| Overall Study | STARTED | Antiarrhythmic Medication | 14 | |
| Overall Study | Switched to the Other Arm | Catheter Ablation | 5 | |
| Overall Study | Switched to the Other Arm | Antiarrhythmic Medication | 1 | |
| Overall Study | COMPLETED | Catheter Ablation | 11 | |
| Overall Study | COMPLETED | Antiarrhythmic Medication | 14 | |
| Overall Study | NOT COMPLETED | Catheter Ablation | 2 | |
| Overall Study | NOT COMPLETED | Antiarrhythmic Medication | 0 |
Source ClinicalTrials.gov
Adverse events60
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Ventricular Tachycardia | Cardiac disorders | Catheter Ablation | 3 | 13 | |
| other | Ventricular Tachycardia | Cardiac disorders | Antiarrhythmic Medication | 2 | 14 | |
| other | Cardiac Failure | Cardiac disorders | Catheter Ablation | 2 | 13 | |
| other | Cardiac Failure | Cardiac disorders | Antiarrhythmic Medication | 1 | 14 | |
| other | Myocardial Infarction | Cardiac disorders | Catheter Ablation | 0 | 13 | |
| other | Myocardial Infarction | Cardiac disorders | Antiarrhythmic Medication | 1 | 14 | |
| other | Hematoma | Vascular disorders | Catheter Ablation | 2 | 13 | |
| other | Hematoma | Vascular disorders | Antiarrhythmic Medication | 0 | 14 | |
| other | Aortic Thrombosis | Vascular disorders | Catheter Ablation | 0 | 13 | |
| other | Aortic Thrombosis | Vascular disorders | Antiarrhythmic Medication | 1 | 14 |
1 to 10 of 60Source ClinicalTrials.gov
See all 60 adverse eventsAdverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Catheter Ablation | ||
| Total, all-cause mortality | Antiarrhythmic Medication | ||
| Total, other adverse events | Catheter Ablation | 7 | 13 |
| Total, other adverse events | Antiarrhythmic Medication | 7 | 14 |
| Total, serious adverse events | Catheter Ablation | 6 | 13 |
| Total, serious adverse events | Antiarrhythmic Medication | 7 | 14 |
Source ClinicalTrials.gov
Papers36
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons8
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Catheter Ablation vs Antiarrhythmic Medication: Number of Participants Switched to Other Arm | Trial comparisons |
| Catheter Ablation vs Antiarrhythmic Medication: Cardiovascular Hospitalizations | Trial comparisons |
| Catheter Ablation vs Antiarrhythmic Medication: Number of Participants Had at Least One of the Efficacy Outcome Measurement | Trial comparisons |
| Catheter Ablation vs Antiarrhythmic Medication: Number of Participants Remained on Randomized Treatment Assignment | Trial comparisons |
| Catheter Ablation vs Antiarrhythmic Medication: Number of Participants Received Treatment Assigned | Trial comparisons |
| Catheter Ablation vs Antiarrhythmic Medication: Number of Participants Completed Month 6 Follow-Up | Trial comparisons |
| Catheter Ablation vs Antiarrhythmic Medication: Number of Participants Completed Month 3 Follow-Up | Trial comparisons |
| Catheter Ablation vs Antiarrhythmic Medication: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01576042
GET https://conductscience.org/api/trials/v1/NCT01576042/events?page=2